Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

476
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
476
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

407
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
407

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness of Fecal Immunochemical Testing Alone vs Co-Testing With Helicobacter pylori Stool Antigen.

JAMA·2026
Same author

Early alcohol initiation is associated with higher lifetime Parkinson's disease risk after accounting for exposure latency.

Journal of Parkinson's disease·2026
Same author

Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan.

Nature communications·2026
Same author

Multistate markov model analysis of metabolic syndrome progression in a community-based longitudinal cohort study.

Diabetology & metabolic syndrome·2026
Same author

Fecal Hemoglobin-Guided Precision Postpolypectomy Surveillance Within the Current Framework: A Four-Million-Participant Fecal Immunochemical Test-Based Screening Study.

Gastroenterology·2026
Same author

Longitudinal Clinical Outcomes of Tissue-Level Dental Implants in a Periodontal Practice: A Retrospective Study.

Clinical implant dentistry and related research·2026

Related Experiment Video

Updated: Sep 13, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.0K

Interval Colorectal Cancers in a Fecal Immunochemical Test-Based Screening Program.

Wen-Feng Hsu1, Uri Ladabaum2, Chiu-Wen Su1

  • 1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

JAMA Network Open
|July 28, 2025
PubMed
Summary

Interval colorectal cancer (CRC) is more common after colonoscopy than after a negative fecal immunochemical test (FIT). Higher adenoma detection rates (ADR) during colonoscopy correlate with worse survival, indicating potential limitations in current screening methods.

More Related Videos

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.1K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

Related Experiment Videos

Last Updated: Sep 13, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.0K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.1K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

Area of Science:

  • Gastroenterology
  • Oncology
  • Public Health

Background:

  • Interval colorectal cancers (CRCs) are diagnosed after negative screening tests or negative colonoscopies.
  • Understanding the risks associated with different screening pathways is crucial for optimizing CRC prevention strategies.

Purpose of the Study:

  • To compare the incidence, mortality, and survival of interval CRC following fecal immunochemical testing (post-FIT interval CRC) versus colonoscopy (postcolonoscopy interval CRC) within Taiwan's screening program.

Main Methods:

  • A cohort study analyzed participants aged 50-74 in Taiwan's CRC Screening Program (2004-2012).
  • Two cohorts were defined: negative FIT results and positive FIT results with negative colonoscopy.
  • Data linkage with Taiwan Cancer Registry and Death Registry (up to 2019) was used to identify interval CRC and survival outcomes.
  • Analysis stratified by hospital-level adenoma detection rate (ADR).

Main Results:

  • Interval CRC incidence and mortality were significantly higher after colonoscopy compared to after a negative FIT.
  • Postcolonoscopy interval CRC incidence was 0.75/1000 person-years vs. 0.09/1000 person-years for post-FIT.
  • Higher hospital-level ADR was associated with lower incidence and mortality of postcolonoscopy interval CRC, but paradoxically, higher CRC-specific death within this subgroup.
  • Adjusted hazard ratios indicated a 7-fold higher incidence and 5-fold higher mortality for postcolonoscopy vs. post-FIT interval CRC.

Conclusions:

  • Individuals with positive FIT results undergoing colonoscopy have a substantially higher risk of developing CRC.
  • Higher ADR during colonoscopy may indicate more thorough examination but is linked to worse survival for interval CRC, suggesting limitations in current colonoscopic surveillance.
  • Further research is needed to explore the interplay between procedural factors and biological aspects influencing CRC outcomes.